EKF Diagnostics (LON:EKF – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX 0.43 EPS for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%.
EKF Diagnostics Price Performance
Shares of LON EKF opened at GBX 29 on Tuesday. EKF Diagnostics has a one year low of GBX 18.40 and a one year high of GBX 32. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The firm’s 50 day simple moving average is GBX 28.46 and its two-hundred day simple moving average is GBX 25. The stock has a market capitalization of £130.24 million, a P/E ratio of 2,101.45 and a beta of 0.57.
EKF Diagnostics Company Profile
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Further Reading
- Five stocks we like better than EKF Diagnostics
- How to Profit From Growth Investing
- 3 Dividend Stocks Raising Payouts in 2025 — With More to Come
- Why is the Ex-Dividend Date Significant to Investors?
- Reddit Hits Record Highs: Why Wall Street Is Taking Notice
- Using the MarketBeat Dividend Yield Calculator
- After a Strong Wall Street Debut, Klarna’s Real Work Begins
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
